Literature DB >> 16540761

Natural history of nonalcoholic steatohepatitis.

Iris Liou1, Kris V Kowdley.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as one of the most common chronic liver diseases. The natural history of this liver disease remains unclear due to its indolent nature, the paucity of prospective studies, and the lack of consensus regarding the various forms of this disorder. Based on retrospective studies, it appears that the histologic features of NAFLD may be important determinants of the clinical course of this disease; patients with nonalcoholic steatohepatitis (NASH) appear to have a higher likelihood of progression to cirrhosis. There is an increased risk of hepatocellular carcinoma and end-stage liver disease among patients with NASH-related cirrhosis and those with cryptogenic cirrhosis, which likely represents a late stage of NAFLD. Recurrence of NASH has been described among patients who have undergone liver transplantation for NASH-related end-stage liver disease.

Entities:  

Mesh:

Year:  2006        PMID: 16540761     DOI: 10.1097/01.mcg.0000168644.23697.31

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  47 in total

1.  A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.

Authors:  Sarah E Hugo; Lourdes Cruz-Garcia; Santhosh Karanth; Ryan M Anderson; Didier Y R Stainier; Amnon Schlegel
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

2.  Rapid progression of NASH in childhood.

Authors:  Rohit Kohli; Todd Boyd; Kathleen Lake; Kim Dietrich; Lynda Nicholas; William F Balistreri; Dawn Ebach; Harohadli Shashidhar; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

3.  Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.

Authors:  Masato Yoneda; Hideki Fujii; Yoshio Sumida; Hideyuki Hyogo; Yoshito Itoh; Masafumi Ono; Yuichiro Eguchi; Yasuaki Suzuki; Noriaki Aoki; Kazuyuki Kanemasa; Kento Imajo; Kazuaki Chayama; Toshiji Saibara; Norifumi Kawada; Kazuma Fujimoto; Yutaka Kohgo; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

4.  Cryptogenic cirrhosis is the leading cause for listing for liver transplantation in Sri Lanka.

Authors:  R C Siriwardana; M A Niriella; C A H Liyanage; S R Wijesuriya; B Gunathilaka; A S Dassanayake; H J De Silva
Journal:  Indian J Gastroenterol       Date:  2013-09-03

5.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

Review 6.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

7.  Identification of unique glycoisoforms of vitamin D-binding protein and haptoglobin as biomarker candidates in hepatocarcinogenesis of STAM mice.

Authors:  Yasunobu Yoshida; Jun-Ichi Furukawa; Shoichi Naito; Kenichi Higashino; Yoshito Numata; Yasuro Shinohara
Journal:  Glycoconj J       Date:  2018-09-08       Impact factor: 2.916

8.  Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.

Authors:  Etsuko Hashimoto; Satoru Yatsuji; Maki Tobari; Makiko Taniai; Nobuyuki Torii; Katsutoshi Tokushige; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

Review 9.  The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

10.  Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors.

Authors:  Tanushree Bose; V Saroja Voruganti; M Elizabeth Tejero; J Michael Proffitt; Laura A Cox; John L VandeBerg; Michael C Mahaney; Jeffrey Rogers; Jeanne H Freeland-Graves; Shelley A Cole; Anthony G Comuzzie
Journal:  Exp Biol Med (Maywood)       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.